Abstract

Exosomes are a group of extracellular microvesicles that deliver biologically active RNAs, proteins, lipids and other signaling molecules to recipient cells. Classically, exosomes act as a vehicle by which cells or organs communicate with each other to maintain cellular/tissue homeostasis and to respond to pathological stress. Most multicellular systems, including the cardiovascular system, use exosomes for intercellular communication. In heart, endogenous exosomes from cardiac cells or stem cells aid in regulation of cell survival, cell proliferation and cell death; and thus tightly regulate cardiac biology and repair processes. Pathological stimulus in heart alters secretion and molecular composition of exosomes, thus influencing the above processes. The past decade has yielded increasing interest in the role of exosomes in the cardiovascular system and significant contribution of cardiac fibroblast (CF) and mediated cardiac fibrosis in heart failure, in this review we had overviewed the relevant literatures about fibroblast exosomes, its effect in the cardiovascular biology and its impact on cardiovascular disease (CVD). This review briefly describes the communication between fibroblasts and other cardiac cells via exosomes, the influence of such on myocardial fibrosis and remodeling, and the possibilities to use exosomes as biomarkers for acute and chronic heart diseases.

Highlights

  • Intracellular communication is important in proficient and appropriate organization and function of various cells in multicellular organs

  • Wang et al (2017) has suggested that Micro ribonucleic acids (RNAs) (miR)-155 in macrophage exosomes has potential to enhance proliferation and differentiation of resident fibroblasts and further exacerbate inflammation. These findings suggest that targeting selective molecules in cardiac fibroblast-derived (CF)-exosomes or inhibition of exosome secretion could be potential therapeutic approaches in heart failure treatment

  • We explore the current understanding of CFs; cardiac fibrosis; exosomes; exosomal biogenesis, structure, composition and involvement in cardiac fibrosis during heart failure

Read more

Summary

INTRODUCTION

Intracellular communication is important in proficient and appropriate organization and function of various cells in multicellular organs. Modulation of miR-375 using a miRNA antagomir in IL-10KO exosomes partially rescued endothelial cell function (Yue et al, 2017) These studies clearly indicate that the direct role of exosomes in CVDs and repair processes and alterations in exosomal contents could be beneficial in the treatment of heart disease. Wang et al (2017) has suggested that miR-155 in macrophage exosomes has potential to enhance proliferation and differentiation of resident fibroblasts and further exacerbate inflammation These findings suggest that targeting selective molecules in cardiac fibroblast-derived (CF)-exosomes or inhibition of exosome secretion could be potential therapeutic approaches in heart failure treatment. We will discuss possibilities of exosomes as biomarkers for cardiac fibrosis and remodeling

CARDIAC FIBROBLASTS AND CARDIAC FIBROSIS
Origin and Activation of Fibroblasts
Stimulator of Cardiac Fibrosis
PARACRINE SIGNALING AND ITS ROLE IN CARDIAC FIBROSIS
Role of Exosomes in Cardiac Fibrosis
Exosomes May Act as a Potential Biomarker in Cardiac Fibrosis
Induce CF Inhibit CF
CONCLUDING AND PROSPECTIVE REMARKS

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.